InvestorsHub Logo
Followers 494
Posts 31943
Boards Moderated 0
Alias Born 03/12/2014

Re: None

Friday, 07/01/2022 10:25:53 PM

Friday, July 01, 2022 10:25:53 PM

Post# of 8921
The FDA has granted Capricor's CAP-1002 RMAT and Orphan Drug Designation, and the Company plans to present this data to the FDA and seek additional guidance on the best path forward for DMD patients.
New FDA commissioner Robert is advocate of Cap 1002
Looks like Capricor plan to meet FDA to persuade AA and confirmation P3 trial this time
I expect some news coining in 2 months
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CAPR News